Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 53,500 |
5 mg | 在庫あり | ¥ 133,000 |
10 mg | 在庫あり | ¥ 211,000 |
25 mg | 在庫あり | ¥ 317,000 |
50 mg | 在庫あり | ¥ 427,000 |
100 mg | 在庫あり | ¥ 571,500 |
500 mg | 在庫あり | ¥ 1,131,500 |
説明 | Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes. |
In vivo | Dose-dependently inhibiting gluconeogenesis (GNG), managlinat dialanetil also lowers basal and postprandial blood glucose levels in Zucker diabetic fatty (ZDF) rats after oral administration[1]. |
別名 | MB06322, MB 6322, CS-917 |
分子量 | 500.55 |
分子式 | C21H33N4O6PS |
CAS No. | 280782-97-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (39.96 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Managlinat dialanetil 280782-97-0 Metabolism Phosphatase MB06322 MB 6322 CS-917 Inhibitor inhibitor inhibit